mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.7 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |